Does dexmedetomidine affect intraoperative blood loss and clotting tests in pediatric adenotonsillectomy patients?
Journal of Surgical Research, ISSN: 0022-4804, Vol: 179, Issue: 1, Page: 94-98
2013
- 18Citations
- 52Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations18
- Citation Indexes17
- 17
- CrossRef12
- Policy Citations1
- Policy Citation1
- Captures52
- Readers52
- 52
Article Description
We hypothesize that dexmedetomidine (DEX), a selective α 2 adrenergic receptor agonist, may affect the intraoperative blood loss and clotting tests such as prothrombin time, activated partial thromboplastin time, and international normalized ratio in children undergoing adenotonsillectomy (ADT). Sixty patients scheduled for elective ADT under general anesthesia. The patients were randomly assigned to receive either DEX 0.5 μg/kg (group D) or placebo bolus (group C) with a total volume of 10 mL, 10 min before the induction of anesthesia. Mean arterial pressure (MAP), heart rate, blood loss, preoperatively and immediately after awakening clotting tests, agitation, sedation, visual analog scale, and analgesic requirement, were assessed and recorded. The postoperative hemoglobin was significantly lower than the preoperative value in both groups ( P < 0.05). The postoperative agitation scale and analgesic requirement and visual analog scale at the 15th min were significantly lower in group D than those in group C ( P < 0.05). Total blood loss and postoperative sedation score in group D was significantly higher than that in group C ( P < 0.05). The postoperative prothrombin time, activated partial thromboplastin time, international normalized ratio tests between the groups, additionally pre-postoperative MAP, heart rate, and clotting tests were similar in each group. The premedication with DEX 0.5 μg/kg decreased postoperative agitation, pain, and analgesic requirement without significant change in the clotting tests and MAP but increased bleeding slightly during ADT.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0022480412008177; http://dx.doi.org/10.1016/j.jss.2012.09.014; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84870717310&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/23122669; https://linkinghub.elsevier.com/retrieve/pii/S0022480412008177; https://dx.doi.org/10.1016/j.jss.2012.09.014
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know